| Application no. and date | 17725544.5 (espacenet) (Federated) (European Patent Register), 20170511 | | Patent/reg. no. and date | DK/EP 3454899, 20240320 | | Publication date | 20190320 | | Priority no. and date | GB 201608323, 20160512 | | EP pub. no. and date |
EP 3454899 20190320 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | | | Inventor | YATES, Andrew Jeffrey, c/o IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 2DT, GB,
MASSANT, Jan Ivo, c/o IPD
UCB Celltech
208 Bath Road
Slough
Berkshire SL1 3WE, GB | | Representative | | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61K 47/26 (2006.01) , A61K 9/08 (2006.01) , A61K 9/19 (2006.01) , C07K 16/28 (2006.01) | | Title | PHARMACEUTICAL COMPOSITION | | Int. application no. | EP2017061261 | | Int. publication no. | WO2017194646 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
